Abstract
Prokaryotic voltage-gated sodium channels (NaVs) are homotetramers and are thought to inactivate through a single mechanism, named C-type inactivation. Here we report the voltage dependence and inactivation rate of the NaChBac channel from Bacillus halodurans, the first identified prokaryotic NaV, as well as of three new homologues cloned from Bacillus licheniformis (NaVBacL), Shewanella putrefaciens (NaVSheP), and Roseobacter denitrificans (NaVRosD). We found that, although activated by a lower membrane potential, NaVBacL inactivates as slowly as NaChBac. NaVSheP and NaVRosD inactivate faster than NaChBac. Mutational analysis of helix S6 showed that residues corresponding to the “glycine hinge” and “PXP motif” in voltage-gated potassium channels are not obligatory for channel gating in these prokaryotic NaVs, but mutations in the regions changed the inactivation rates. Mutation of the region corresponding to the glycine hinge in NaVBacL (A214G), NaVSheP (A216G), and NaChBac (G219A) accelerated inactivation in these channels, whereas mutation of glycine to alanine in the lower part of helix S6 in NaChBac (G229A), NaVBacL (G224A), and NaVRosD (G217A) reduced the inactivation rate. These results imply that activation gating in prokaryotic NaVs does not require gating motifs and that the residues of helix S6 affect C-type inactivation rates in these channels.
Keywords: Channels/Ion, Channels/Sodium, Membrane/Channels, Membrane/Proteins, Protein/Motifs, Protein/Purification
Introduction
Voltage-gated sodium channels (NaVs)3 generate the rapid upstroke of action potentials in nerve cell axons (1). In mammalian NaVs, the channel is formed by the α-subunit, which comprises four repeats of six-transmembrane segments, with each repeat consisting of 300–400 amino acids. The α-subunit carries several glycosylation sites and co-assembles with auxiliary subunits to form the native channel (2, 3). The only structural information on NaVs available to date is a density map of the NaV from the electric organ of the electric eel determined by cryoelectron microscopy (4). Due to its limited resolution of 19 Å, the density map did not provide insights into the gating or sodium selectivity.
The first prokaryotic NaV, NaChBac, was cloned from Bacillus halodurans (5). Subsequently, three more prokaryotic sodium channels were cloned and characterized (6, 7). All studied prokaryotic NaVs form homotetramers with a structure thought to be similar to that of some potassium channels with known structures (8–10). Furthermore, because the proteins could be expressed in large amounts in Escherichia coli and purified by metal chelate affinity chromatography (5, 7, 11), they are promising candidates for high resolution structure determination and structure-function analyses.
The physiological role of prokaryotic NaVs may be related to pH homeostasis, motility, and chemotaxis (6, 12). Searching bacterial genomic data bases, we found 26 sequences of putative NaChBac homologues from bacteria living in various environments. We were able to clone the putative NaV genes from three of these bacteria, Bacillus licheniformis, Shewanella putrefaciens, and Roseobacter denitrificans, and named them NaVBacL, NaVSheP, and NaVRosD, respectively. These homologues showed unique channel properties optimized for the specific environments in which the bacteria live.
We found an unexpected feature in the primary structure of NaVSheP, namely a lack of glycine residues in helix S6. Crystal structures of potassium channels revealed that glycine and proline residues in helix S6 that are part of the “glycine hinge” and “PXP motif,” respectively, create kinks in the open state (13–15). It has therefore been thought that these residues are critical for activation gating in tetrameric cation channels (15–19). Although NaVSheP contains no glycine residues in helix S6, it still shows typical inward currents. To better understand their role, we mutated the glycine residues in helix S6 of NaVBacL, NaVRosD, and NaChBac to alanine. All mutants retained inward sodium currents. These results suggest that the previously proposed gating motifs are not obligatory for activation of prokaryotic NaVs.
The glycine mutations had no effect on activation but affected inactivation of the channels. Generally, voltage-gated cation channels are immediately inactivated after activation. Tetrameric cation channels have mainly two inactivation mechanisms, N-type and C-type inactivation (20–25). N-type or fast inactivation is thought to be mediated by the interdomain linkers of NaVs or the N termini of voltage-gated potassium channels, a mechanism described by the “ball and chain” model (20–22). Although C-type inactivation is common in tetrameric cation channels, its molecular mechanism remains unclear. It has been proposed that C-type inactivation may be related to a collapse of the selectivity filter (23–25). Prokaryotic NaVs lack an obvious cytoplasmic N-type inactivation peptide, and inactivation may thus only occur through the C-type inactivation mechanism (25, 26). Furthermore, comparative studies and mutational analysis of these new NaV homologues provide evidence that the rate of C-type inactivation is affected by the residues of helix S6.
EXPERIMENTAL PROCEDURES
Cloning of NaChBacs Homologues and Site-directed Mutagenesis
The NaChBac amino acid sequence (NP_242367) was used as a query for a BLASTP search against the Microbial Genomic data base at NCBI. The identified primary sequence data were obtained from Entrez at NCBI (B. licheniformis ATCC 14580 DSM 13 as NC_006270, Loktanella vestfoldensis SKA53 as NZ_AAMS01000001, Rhodobacter sphaeroides ATCC 17025 as NZ_AAME01000021, S. putrefaciens CN-32 as NZ_AALB00000000, R. denitrificans OCh 114 as NC_008209, and Oceanicaulis alexandrii HTCC2633 as NZ_AAMQ01000008). Samples of B. licheniformis (Japan Collection of Microorganisms number 2505), L. vestfoldensis (Japan Collection of Microorganisms number 21637) and R. sphaeroides (Japan Collection of Microorganisms number 6121) were obtained from the RIKEN BioResource Center. Samples of S. putrefaciens (National Institute of Technology and Evaluation Biological Resource Center number 3908), R. denitrificans (National Institute of Technology and Evaluation Biological Resource Center number 15277), and Oceanicaulis sp. (National Institute of Technology and Evaluation Biological Resource Center number 101722), closely related to O. alexandrii by 16 S rRNA sequence analysis, were obtained from the National Institute of Technology and Evaluation. DNAs of NaChBac homologues were directly cloned by PCR from colonies of bacteria using PrimeSTAR® GXL DNA Polymerase (Takara Bio.).
The following primers were used for cloning: 5′-CGCGGATCCATGAACACTCATCAAAATCGA-3′ and 5′-CGCGGATCCATCTTTCTTTTCATTTTGGGT-3′ for B. licheniformis; 5′-CGCGGATCCATGAGTACATCTTTACTT-3′ and 5′- CGCGGATCCGTCAGAACCAATGTTTCC-3′ for S. putrefaciens; 5′-CGCGGATCCATGGGTGTAAGAGAGCAA-3′ and 5′-CGCGGATCCGGACCGGGGCCTGTCTTT-3′ for R. denitrificans; 5′-CGCGGATCCATGAATTTGCGCGCCAGAACA-3′ and 5′-CGCGGATCCCTTGCCCGCCTGATCCAGTCG-3′ for L. vestfoldensis; 5′-CGCGGATCCATGACAGTGCGGGAAATGGTA-3′ and 5′-CGCGGATCCGCCGCGCGTCTCGTCGCCCGC-3′ for R. sphaeroides; and 5′-CGCGGATCCATGAGCGACGCGTCGGCC-3′ and 5′-CGCGGATCCCTCGGAATTGTCCGCCCG-3′ for O. alexandrii.
PCR products were cloned into a modified pET21b plasmid (Novagen) using BamHI restriction sites. These cloned DNAs contained additional methionine, glycine, and serine codons before the first methionine and a thrombin cleavage site before the C-terminal His tag. For expression in mammalian cells, three NaChBac homologues (NaVBacL from B. licheniformis, NaVSheP from S. putrefaciens, and NaVRosD from R. denitrificans) were subcloned into the pCI vector (Promega) using the NheI and KpnI sites. Site-directed mutagenesis was accomplished by PCR of the full-length pCI plasmid containing the NaV gene using high fidelity Pfu DNA polymerase (method by Stratagene). All clones were confirmed by DNA sequencing.
Expression and Purification of Recombinant Prokaryotic NaVs
Proteins were expressed in E. coli BL21 ΔstarTM (DE3) (Invitrogen). 100 ml of LB medium (Invitrogen) containing 100 μg/ml ampicillin (Wako) was inoculated with 10 μl of glycerol stock and incubated overnight at 37 °C. 12.5 ml of the saturated culture medium was then used to inoculate 1.25 liters of LB medium containing 40 μg/ml ampicillin, and cells were grown at 37 °C to an A600 of 0.8. Cells were induced with 0.5 mm isopropyl 1-thio-β-d-galactopyranoside (Wako) and grown for 16 h at 18 °C. Cells were suspended in TBS buffer (20 mm Tris-HCl, pH 7.4, 300 mm NaCl) and lysed using a French press (SLM AMINCO) at 12,000 p.s.i. Membranes were collected by centrifugation (100,000 × g, 1 h, 4 °C) and solubilized by homogenization in TBS buffer containing 40 mm CYMAL-5 (Anatrace). After centrifugation (40,000 × g, 30 min, 4 °C), the supernatant was loaded onto a HIS-Select® cobalt affinity gel column (Sigma). The column was washed with 10 mm imidazole in TBS buffer containing 8 mm CYMAL-5, and the protein was eluted with 300 mm imidazole. Purified proteins were resolved on 10–20% SDS-PAGE gradient gels (Wako) and stained with Coomassie Blue. The BenchMarkTM prestained protein ladder (Invitrogen) was used as molecular weight markers.
Mass Spectrometry
Mass spectrometry was carried out with a MALDI-TOF instrument (Voyager-DE, Applied Biosystems), using α-cyanohydroxycinnamic acid (Sigma) as matrix. Protein samples were mixed with the same volume of 90% acetonitrile (Wako) and 0.2% trifluoroacetic acid (Sigma), loaded onto a sample plate, dried, and washed with deionized water. Finally, 1% α-cyanohydroxycinnamic acid dissolved in 50% acetonitrile and 0.1% trifluoroacetic acid was loaded onto the dried samples. Mass spectra were collected using the delayed extraction mode.
Mammalian Electrophysiology
Chinese hamster ovary (CHO)-K1 or human embryonic kidney (HEK) 293 cells were grown in Dulbecco's modified Eagle's medium (Sigma) complemented with 10% fetal bovine serum (BioWhittaker), 100 units/ml penicillin (Invitrogen), and 100 μg/ml streptomycin (Invitrogen) at 37 °C under 5% CO2. Cells were transfected with NaV and pEGFP DNA using the calcium phosphate transfection kit (Invitrogen) and plated onto coverslips. Currents were recorded 12 h (NaVBacL and NaVSheP) or 36 h (NaVRosD and NaChBac) after transfection. The pipette solution contained 105 mm CsF, 35 mm NaCl, 10 mm EGTA, and 10 mm HEPES (pH 7.4). The bath solution contained 150 mm NaCl, 1.5 mm CaCl2, 1 mm MgCl2, 2 mm KCl, 10 mm HEPES (pH 7.4), and 10 mm glucose. For measurements of the voltage dependence of NaVBacL and NaVSheP, 150 mm NaCl in the bath solution was replaced by 75 mm NaCl and 75 mm N-methyl-d-glucamine. All experiments were conducted at 25 ± 2 °C. Nifedipine (Sigma) was dissolved in DMSO (Wako). The final concentration of the solvent was less than 1%. Whole-cell patch clamp recordings of wild-type NaChBac confirmed that 1% DMSO did not affect the channel activity. All chemicals were dissolved in water. All other compounds were applied to the cultured cells using a perfusion system. For pharmacological measurements, cells were perfused with bath solution containing the inhibitors for 5 min prior to recording currents. All results are presented as mean ± S.E. A simple comparison between NaVBacL wild type and G201A was made by Student's t test. To assess statistical differences in time constants between wild type and mutant proteins, multiple comparisons were made by one-way analysis of variance followed by the Tukey-Kramer multiple comparisons test.
RESULTS
We used the full NaChBac sequence for a standard BLASTP search against the GenBankTM data base of prokaryotic genomic sequences. The BLASTP search yielded 34 sequences that contained both a “TLESW” sequence, the putative selectivity filter of prokaryotic sodium channels (5–7), and positively charged amino acids at every third position in helix S4, the hallmark of voltage sensors (3, 5) (Fig. 1). The channel activity of four of the identified homologues (NaChBac as NP242367, NaVBP as AAR21291, NaVPZ as CAD24429, and NaVSP as AY392137) had already been established (5–7), whereas four other homologues (NP 693313 of Oceanobacillus iheyensis HTE831, ZP 00067595 of Microbulbifer degradans 2-40, Ay392141 of Colwellia psychrerythraea 34H, and ZP 00043768 of Magnetococcus sp. MC-1) showed no channel activity in previous studies (7). Of the bacteria containing the remaining 26 homologues, six of them were commercially available: B. licheniformis, isolated from soil and plant material (27), and L. vestfoldensis (28), R. sphaeroides (29), S. putrefaciens (30), R. denitrificans (31), and Oceanicaulis sp. (32) isolated from sea water (28–33). Using the colony-direct PCR method, we were able to clone the putative NaV genes from three of these six bacteria, namely from B. licheniformis, S. putrefaciens, and R. denitrificans.
Sequencing of the NaVBacL gene from B. licheniformis revealed an open reading frame of 276 amino acids with a predicted molecular size of 31.8 kDa, and sequencing of the NaVRosD gene from R. denitrificans showed an open reading frame of 259 amino acids (29.2 kDa). Both sequences were identical with the deposited sequences. Our sequence of the NaVSheP gene from S. putrefaciens, encoding an open reading frame of 295 amino acids (33.1 kDa), differed, however, from the sequence deposited in the GenBankTM data base in several places (T31A, A54T, V62L, and N88S) (Fig. 2A). NaVBacL, NaVSheP, and NaVRosD share with NaChBac sequence identities (sequence similarities) of 49% (57%), 32% (44%), and 37% (48%), respectively, and hydropathy plots predict a six-transmembrane architecture for all three proteins (Fig. 2A).
C-terminally His-tagged constructs of all three NaVs expressed well in E. coli and could be purified by metal chelate affinity chromatography (Fig. 2B). NaVBacL and NaVRosD migrated as a single band on SDS-polyacrylamide gels (∼34 and ∼25 kDa, respectively), whereas NaVSheP migrated mainly as a ∼35 kDa band but also showed additional smaller bands. The smaller bands could also be detected on Western blots probed with anti-His antibodies (data not shown). Mass spectra confirmed that all main bands represented the full-length proteins and identified the molecular masses of the smaller bands of NaVSheP as 22,662 and 23,053 Da (Fig. 2C). The additional bands thus represent C-terminal fragments of NaVSheP that were generated by cleavage of the carboxyl group of residues Arg110, the first arginine of helix S4, and Ala107 (Fig. 2A).
We transfected mammalian cell lines (CHO-K1 or HEK 293) with the genes encoding NaVBacL, NaVSheP, and NaVRosD and measured the resulting currents (Fig. 3). Although no currents were observed in non-transfected or mock-transfected cells (data not shown), currents could be recorded from cells transfected with the NaV genes, and all three channels required at least 1 s for 90% recovery from inactivation. Cells transfected with each of the three NaVs exhibited large voltage-activated inward currents of up to 10 nA (Fig. 3, A–C), peaking at −40, −50, and −10 mV for NaVBacL, NaVSheP, and NaVRosD, respectively (Fig. 3, D–F). The reversal potential of NaVRosD-mediated current (INaVRosD) was +42.7 mV in a bath solution containing 150 mm Na+. The inward currents produced by NaVBacL and NaVSheP in a bath solution containing 150 mm Na+ were, however, peaking at a membrane potential that was too low to clamp the membrane potentials at low voltage. To measure the currents produced by NaVBacL and NaVSheP, we therefore reduced the NaCl concentration in the bath solution from 150 to 75 mm and added instead 75 mm N-methyl-d-glucamine. The reversal potential of INaVBacL and INaVSheP could then be determined as +28.3 and +33.0 mV, respectively. Ion substitution (Ca2+, K+, and N-methyl-d-glucamine replacement) confirmed that all three proteins form Na+-selective channels and that they are sensitive to high concentrations of nifedipine (30 μm) (data not shown). Their pharmacological sensitivity closely resembles that of L-type CaVs, as already reported for the previously characterized homologues (5–7).
INaVBacL was activated with a time constant (τactivation) of 4.92 ± 0.73 ms at +10 mV (n = 15) and inactivated with τinactivation of 96.1 ± 9.60 ms at +10 mV (n = 15). Both time constants were significantly larger than those of mammalian NaV channels (τactivation = 2 ms; τinactivation = 10 ms) but faster than those of INaChBac (τactivation = 12.9 ms; τinactivation = 166 ms) (5). INaVSheP (τactivation = 0.89 ± 0.076 ms at −10 mV, n = 17; τinactivation = 9.90 ± 0.57 ms at −10 mV, n = 17) and INaVRosD (τactivation = 1.61 ± 0.12 ms at +20 mV, n = 15; τinactivation = 9.88 ± 1.25 ms at +20 mV, n = 15) were activated and inactivated significantly faster than INaVBacL and INaChBac. Remarkably, the time constants of them were as small as those of the α-subunit of the rat skeletal muscle-type NaV (34).
We evaluated the voltage-dependent activation of NaVBacL by measuring deactivation tail currents (Fig. 4A). A Boltzmann fit of the averaged activation curve yielded an activating potential of 50% activation (V½) of −63.7 ± 1.8 mV (n = 9) and a slope factor (κ) of 13.5 ± 1.7 mV/e-fold change in current (Fig. 4C). The steady-state inactivation of the channel was determined by sequential depolarization to test voltages, followed by voltage clamp to the peak of activation at −20 mV (Fig. 4B). Steady-state inactivation was a steep function of voltage, with 50% inactivation at −83.2 ± 0.7 mV (n = 9) and κ = 5.8 ± 0.6 mV/e-fold change (Fig. 4C). Although NaVBacL had similar time constants of activation and inactivation as NaChBac (5), NaVBacL activated and inactivated at voltages about 40 mV lower than those of NaChBac (Table 1).
TABLE 1.
Boltzmann fits of their activation curves yielded V½ of −80.0 ± 0.9 mV and κ of 7.4 ± 0.8 mV/e-fold change for NaVSheP (n = 6; Fig. 4, D and F) and V½ of −25.9 ± 1.2 mV and κ of 9.9 ± 1.1 mV/e-fold change for NaVRosD (n = 6; Fig. 4, G and I). The steady-state inactivation of NaVSheP and NaVRosD were dependent on the voltage with half-inactivations at −116.5 ± 0.9 mV (κ = 9.5 ± 0.9 mV/e-fold) (n = 6; Fig. 4, E and F) and −78.7 ± 1.6 mV (κ = 10.7 ± 1.6 mV/e-fold) (n = 6; Fig. 4, H and I), respectively. NaVSheP activated and inactivated at the lowest membrane potential of all NaChBac homologues studied to date. The voltage dependences of the three prokaryotic NaVs analyzed in this study are summarized in Table 1.
Previous studies indicated that a glycine residue in the middle of helix S6, named the “glycine hinge,” is critical for gating of tetrameric cation channels (15–17). A glycine residue corresponding to the glycine hinge is present in NaChBac (Gly219) but not in NaVBacL (Ala214), NaVSheP (Ala216), and NaVRosD (Thr207) (red arrow in Fig. 5A). Other glycine residues in NaVBacL (Gly224), NaVRosD (Gly217), and also NaChBac (Gly229) are found in the lower part of helix S6. This part is near the cytoplasmic side and corresponds to the position of the PXP motif, a Pro-X-Pro or glycine motif that is important for gating in hERG (human ether-a-go-go related gene) and KV channels (18, 19) (green arrow in Fig. 5A) and creates a kink in helix S6 of KV1.2 (Fig. 5C). By contrast, NaVSheP contains no glycine residues in helix S6 (Fig. 5A).
To evaluate their role, we mutated the glycines in helix S6 of NaVBacL, NaVRosD, and NaChBac to alanine, a residue known to strongly stabilize α-helical secondary structure (35). All mutants retained the channel currents, but their time constants of inactivation changed significantly. On the other hand, their activation rates and also voltage dependences were less influenced by the mutations. Table 2 summarizes the τactivation and τinactivation values of all analyzed mutant and wild-type channels as well as the statistical differences in τinactivation between the wild-type channels and the various mutants. As a control, we made an alanine substitution of residue Gly201 in NaVBacL, which is located in the pore-S6 loop (blue arrow in Fig. 5A). This mutation had no effect on the time constant of inactivation (Table 2). With τinactivation of 21.4 ± 2.19 ms at +10 mV, the NaChBac G219A mutant showed faster inactivation than wild-type NaChBac (p < 0.01) (Fig. 5D). NaChBac G229A (τinactivation = 230 ± 33.8 ms at +10 mV), NaVBacL G224A (τinactivation = 270 ± 53.3 ms at +10 mV), and NaVRosD G217A (τinactivation = 60.9 ± 13.0 ms at +20 mV) showed significantly slower inactivation than the corresponding wild-type channels (p < 0.01) (Fig. 5, D–F). Inactivation of the NaChBac G219A/G229A double mutant (τinactivation = 156 ± 16.2 ms at +10 mV) showed no statistically relevant difference compared with the inactivation of the wild-type protein and was significantly slower than that of NaChBac G219A (Fig. 5D). All mutants lacking glycine residues in helix S6 still showed activation and inactivation.
TABLE 2.
Time constant |
Statistical significance ofτinactivation |
No. of measurements | ||||
---|---|---|---|---|---|---|
τactivation | τinactivation | WT | G219A | G229A | ||
ms | ||||||
NaChBac | 3.73 ± 0.73 | 118 ± 10.2 | 13 | |||
NaChBac G219A | 0.95 ± 0.22 | 21.4 ± 2.19 | p < 0.01 | 5 | ||
NaChBac G229A | 12.0 ± 3.33 | 230 ± 33.8 | p < 0.01 | p < 0.01 | 5 | |
NaChBac G219A/G229A | 2.86 ± 0.47 | 156 ± 16.2 | NS | p < 0.01 | p < 0.05 | 11 |
WT | A214G | G224A | ||||
NaVBacL | 4.92 ± 0.73 | 96.1 ± 9.60 | 15 | |||
NaVBacL A214G | 1.70 ± 0.27 | 29.5 ± 3.14 | p < 0.01 | 11 | ||
NaVBacL G224A | 3.69 ± 1.21 | 270 ± 53.3 | p < 0.01 | p < 0.01 | 5 | |
NaVBacL A214G/G224A | 4.63 ± 0.57 | 54.1 ± 4.51 | NS | NS | p < 0.01 | 9 |
NaVBacL G201A | 2.20 ± 0.32 | 81.0 ± 12.6 | NSa | 7 | ||
WT | A216G | G226A | ||||
NaVSheP | 0.89 ± 0.076 | 9.90 ± 0.57 | 17 | |||
NaVSheP A216G | 0.82 ± 0.10 | 5.35 ± 0.72 | p < 0.01 | 8 | ||
NaVSheP A226G | 0.85 ± 0.08 | 11.6 ± 0.50 | NS | p < 0.01 | 9 | |
NaVSheP A216G/A226G | 0.87 ± 0.10 | 7.61 ± 0.65 | p < 0.05 | NS | p < 0.01 | 10 |
WT | G217A | |||||
NaVRosD | 1.61 ± 0.12 | 9.88 ± 1.25 | 15 | |||
NaVRosD G217A | 2.06 ± 0.45 | 60.9 ± 13.0 | p < 0.01 | 7 | ||
NaVRosD T207G/G217A | 2.92 ± 0.63 | 20.93 ± 3.90 | NS | p < 0.01 | 6 |
a A simple comparison between NaVBacL wild type and G201A was made by Student's t test.
NaVBacL, NaVSheP, and NaVRosD do not have a glycine at the position that corresponds to the glycine hinge in helix S6. When the residues in this position were mutated to glycine, the mutants, with the exception of NaVRosD T207G (see below), also produced measurable inward currents (more than 1 nA) (Fig. 5, D–F). Furthermore, NaVBacL A214G (τinactivation = 29.5 ± 3.14 ms at +10 mV) and NaVSheP A216G (τinactivation = 5.35 ± 0.72 ms at −10 mV) showed significantly faster inactivation than the respective wild-type channels (p < 0.01) (Fig. 5, E–G). NaVRosD T207G showed only a small and fast inactivated current (∼200 pA; τinactivation < 2 ms). Because HEK293 or CHO-K1 cells express endogenous sodium channels that produce similar small currents (36), the current produced by the NaVRosD T207G mutant could not be distinguished from that produced by the endogenous sodium channels. Ala226 of NaVSheP is the residue in the region in the lower part of helix S6 that corresponds to the PXP motif in voltage-dependent potassium channels (green arrow in Fig. 5A). The inactivation rate of NaVSheP A226G (τinactivation = 11.6 ± 0.50 ms at −10 mV) was slightly slower than that of the wild-type channel, but the difference is not statistically significant (Fig. 5F). Double mutation of two residues also retained the inward current of sodium ions. The inactivation rate of NaVBacL A214G/G224A (τinactivation = 54.1 ± 4.51 ms at +10 mV, n = 9) was significantly faster than that of NaVBacL G224A (p < 0.01) and slower than that of NaVBacL A214G, although the difference was not statistically significant (Fig. 5E). NaVSheP A216G/A226G (τinactivation = 7.61 ± 0.65 ms at −10 mV) inactivated as fast as NaVSheP A216G. NaVRosD T207G/G217A (τinactivation =20.93 ± 3.90 ms at +20 mV) produced a current less than 500 pA. This current could be distinguished from that of endogenous sodium channels and showed a faster inactivation than NaVRosD G217A (p < 0.01). In summary, mutations of the residues corresponding to the glycine hinge accelerated the inactivation rate, mutations of glycines in the lower part of helix S6 to alanine reduced the inactivation rate, and the A226G mutation in NaVSheP had no effect on the inactivation rate.
DISCUSSION
We cloned three new NaChBac homologues from B. licheniformis, S. putrefaciens, and R. denitrificans. The three channels differ in their kinetics and voltage dependences, which may reflect differences in the environment in which the respective bacteria live. The physiological role of the NaV homologue found in the alkaliphilic bacterium Bacillus pseudofirmus, NaVBP, has been well studied (6, 12). Deletion of NaVBP resulted in impaired pH homeostasis and reversed pH chemotaxis (6). These results suggest that NaVBP functions in conjunction with the multiple resistance and pH adaptation Na+/H+ antiporter in pH homeostasis, with the sodium-driven motor protein complex in motility (6), and with the methyl-accepting chemotaxis proteins in chemotaxis (12). Multiple resistance and pH adaptation antiporters (37), sodium-driven motor protein complex (38), and methyl-accepting chemotaxis proteins (39) are found in many bacteria, and prokaryotic NaVs might thus play the same roles in other bacteria as NaVBP in B. pseudofirmus.
Because bacteria live in environments that differ in pH, temperature, and ionic conditions, it seems reasonable that they express NaVs with channel properties that have adapted to their specific environments. First, activation and inactivation of prokaryotic NaVs cloned from marine bacteria (NaVSP, NaVSheP, and NaVRosD but not NaVPZ) were faster than those of homologues cloned from Bacillus species (NaChBac, NaVBP, and NaVBacL) (Table 2). Marine bacteria live in an environment with a higher concentration of sodium ions than soil bacteria, such as Bacillus species. The fast inactivation of NaVs found in marine bacteria might thus be an adaptation that evolved to prevent the influx of excess sodium ions into the cytoplasm. Second, although NaVBacL and NaVBP, both expressed in Bacillus species isolated from soil, have similar kinetics of activation and inactivation, their voltage dependences differ from each other. At the neutral pH of 7.4, half of NaVBP is activated by a voltage of −35 mV and inactivated by a voltage of −57 mV (6) (Table 1). These membrane potentials are 30 mV higher than those that activate and inactivate NaVBacL. At pH 9.0, the pH of the environment in which B. pseudofirmus lives, half of NaVBP is, however, activated by a voltage of −64 mV and inactivated by a voltage of −86 mV (6). Hence, at the pH of the environment in which the respective bacterium lives, the two channels have similar voltage dependences of activation and inactivation. This finding suggests that the channel characteristics of prokaryotic NaVs have been optimized for the specific environments of the bacteria.
The diversity in the channel properties of prokaryotic NaVs can help us to obtain a better understanding of the molecular mechanisms that underlie ion channel function. The crystal structure of the KV1.2/KV2.1 chimera potassium channel suggested that the S4-S5 linker helix pushes down on the lower part of helix S6 and thus keeps the ion pore closed in the resting state (13). A single molecule study demonstrated that this region of KcsA is rotated in the open state (40) and thus confirmed that this region works as an activation gate. If the pore domain were folded tightly, such as seen in crystal structures of potassium channels, the role of the glycine hinge and the PXP motif in channel gating might be to provide sufficient flexibility to allow the lower part of helix S6 to bend and move for activation. On the other hand, prokaryotic NaV mutants lacking glycine and proline residues in helix S6 and wild-type NaVSheP still show activation and inactivation (Fig. 5 and Table 2). Neither motif can thus be essential for gating in prokaryotic NaVs. Because bending of helix S6 would be difficult without such gating motifs, it is likely that in these mutants and in wild-type NaVSheP, the entire helix S6 has to incline to open the activation gate. Therefore, it is likely that the pore domain of prokaryotic NaVs is folded more loosely to increase the mobility of helix S6.
Inactivation of prokaryotic NaVs is thought to occur through the C-type inactivation mechanism seen in other tetrameric cation channels. C-type inactivation has been explained by conformational changes around the selectivity filter of the channel (23–25). These conformational changes, which cause the selectivity filter to collapse, act as an inactivation gate. Therefore, the stability of the selectivity filter could affect the rate of C-type inactivation. In the case of KcsA, it has been proposed that the residues adjacent to Gly99, which is the residue corresponding to the glycine hinge, interact with residues forming the bottom of the selectivity filter, thus stabilizing its conductive conformation (41). This motif of Kv1.2 also locates beside the selectivity filter (Fig. 5, B and C). Based on the similarity of the primary sequences, the corresponding region in prokaryotic NaVs would also be near their selectivity filters. All mutations in this region in NaVBacL (A214G), NaVSheP (A216G), NaVRosD (T207G), and also NaChBac (G219A) accelerated the inactivation rate. Remarkably, the T207G mutation reduced ion currents in NaVRosD T207G and NaVRosD T207G/G217A. These mutations would be expected to make the selectivity filter less stable and easier to collapse. As a result, the mutants would inactivate faster than the respective wild-type channels.
The lower part of helix S6 is thought to act as activation gate (13, 40). C-type inactivation always occurs after activation and thus appears to be coupled to activation. The coupling between the activation and inactivation gates is thought to be mediated by residues adjacent to the glycine hinge in helix S6 and the bottom of the selectivity filter (41). Our glycine-to-alanine mutations in the lower part of helix S6 reduced the inactivation rate. This result suggests that the glycine-to-alanine mutations, which stabilize the lower part of helix S6, weaken the coupling between the activation and inactivation gates and thus delay inactivation. NaVSheP is the only channel in which the alanine-to-glycine mutation (A226G) showed no effect. It thus appears that although this region is important for the coupling in other channels, it may not have the same importance for coupling in NaVSheP. This notion is supported by the fact that NaVSheP lacks glycines in helix S6 and may thus use a coupling mechanism that in its details differs from that of other prokaryotic NaVs. In a previous report, a G219P mutation in NaChBac eliminated C-type inactivation (16). However, this glycine residue is not obligatory for activation gating. Therefore, the G219P mutation might force helix S6 to adopt an unusual bent conformation, in which helix S6 would not be able to mediate the coupling between the activation and inactivation gates.
Double mutations in the region corresponding to the glycine hinge and the lower part of helix S6 independently affected the inactivation rate in NaVBacL, NaVRosD, and NaChBac. It is possible that other regions in helix S6 are also involved in C-type inactivation. Nevertheless, the mutational results at these two regions may serve as useful footholds for the study of C-type inactivation. All mutations in this study had stronger effects on the inactivation rate than on the activation rate. The driving force for activation is depolarization, whereas C-type inactivation is due to the collapse of the selectivity filter, which depends on thermal instability. It is thus not unexpected that C-type inactivation is more sensitive to mutations than channel activation. Although these results provide first clues to the coupling of activation and inactivation in voltage-gated cation channels, a deep understanding of this phenomenon will require further mutational studies as well as the analysis of atomic structures.
Without knowing the three-dimensional structure of NaV channels, it is impossible to understand the sodium selectivity of these channels and how small changes in their primary sequences result in different voltage dependences and gating kinetics. A high resolution structure is particularly crucial for understanding the structural basis of sodium selectivity. Because the three NaVs characterized in this study could be expressed at high levels and purified in large amounts, they are promising candidates for structural studies and thus increase the chances of obtaining a high resolution crystal structure.
Prokaryotic NaVs are the simplest voltage-gated cation channels known to date. They are composed of fewer than 300 amino acids, and differences in their channel characteristics are due to small changes in their primary sequences. As functional analyses proceed and structures become available, prokaryotic NaVs have the potential not only to reveal the basic molecular mechanisms of voltage-gated cation channels but also to provide insight into the molecular evolution of these channels.
Acknowledgments
We thank Dr. Chikara Sato (Advanced Industrial Science and Technology, Neuroscience Research Institute) for kindly providing NaChBac DNA and Drs. Christoph Gerle and Kentaro Noma for valuable discussions. We are grateful to Dr. Thomas Walz for critical reading of the manuscript.
This work was supported in part by Grants-in-Aid for Specially Promoted Research and the Japan New Energy and Industrial Technology Development Organization.
- NaV
- voltage-gated sodium channel
- KV
- voltage-gated potassium channel
- MALDI
- matrix-assisted laser desorption ionization
- TOF
- time-of-flight
- CHO
- Chinese hamster ovary
- HEK
- human embryonic kidney.
REFERENCES
- 1.Hille B. (2001) Ion Channels of Excitable Membranes, 3rd Ed., Sinauer Associates, Sunderland, MA [Google Scholar]
- 2.Catterall W. A. (1992) Physiol. Rev. 72, S15–S48 [DOI] [PubMed] [Google Scholar]
- 3.Catterall W. A. (1995) Annu. Rev. Biochem. 64, 493–531 [DOI] [PubMed] [Google Scholar]
- 4.Sato C., Ueno Y., Asai K., Takahashi K., Sato M., Engel A., Fujiyoshi Y. (2001) Nature 409, 1047–1051 [DOI] [PubMed] [Google Scholar]
- 5.Ren D., Navarro B., Xu H., Yue L., Shi Q., Clapham D. E. (2001) Science 294, 2372–2375 [DOI] [PubMed] [Google Scholar]
- 6.Ito M., Xu H., Guffanti A. A., Wei Y., Zvi L., Clapham D. E., Krulwich T. A. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 10566–10571 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Koishi R., Xu H., Ren D., Navarro B., Spiller B. W., Shi Q., Clapham D. E. (2004) J. Biol. Chem. 279, 9532–9538 [DOI] [PubMed] [Google Scholar]
- 8.Doyle D. A., Morais Cabral J., Pfuetzner R. A., Kuo A., Gulbis J. M., Cohen S. L., Chait B. T., MacKinnon R. (1998) Science 280, 69–77 [DOI] [PubMed] [Google Scholar]
- 9.Jiang Y., Lee A., Chen J., Ruta V., Cadene M., Chait B. T., MacKinnon R. (2003) Nature 423, 33–41 [DOI] [PubMed] [Google Scholar]
- 10.Jiang Y., Lee A., Chen J., Cadene M., Chait B. T., MacKinnon R. (2002) Nature 417, 515–522 [DOI] [PubMed] [Google Scholar]
- 11.Nurani G., Radford M., Charalambous K., O'Reilly A. O., Cronin N. B., Haque S., Wallace B. A. (2008) Biochemistry 47, 8114–8121 [DOI] [PubMed] [Google Scholar]
- 12.Fujinami S., Sato T., Trimmer J. S., Spiller B. W., Clapham D. E., Krulwich T. A., Kawagishi I., Ito M. (2007) Microbiology 153, 4027–4038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Long S. B., Tao X., Campbell E. B., MacKinnon R. (2007) Nature 450, 376–382 [DOI] [PubMed] [Google Scholar]
- 14.Alam A., Jiang Y. (2009) Nat. Struct. Mol. Biol. 16, 30–34 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jiang Y., Lee A., Chen J., Cadene M., Chait B. T., MacKinnon R. (2002) Nature 417, 523–526 [DOI] [PubMed] [Google Scholar]
- 16.Zhao Y., Yarov-Yarovoy V., Scheuer T., Catterall W. A. (2004) Neuron 41, 859–865 [DOI] [PubMed] [Google Scholar]
- 17.Ding S., Ingleby L., Ahern C. A., Horn R. (2005) J. Gen. Physiol. 126, 213–226 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Hardman R. M., Stansfeld P. J., Dalibalta S., Sutcliffe M. J., Mitcheson J. S. (2007) J. Biol. Chem. 282, 31972–31981 [DOI] [PubMed] [Google Scholar]
- 19.Labro A. J., Raes A. L., Bellens I., Ottschytsch N., Snyders D. J. (2003) J. Biol. Chem. 278, 50724–50731 [DOI] [PubMed] [Google Scholar]
- 20.Armstrong C. M., Bezanilla F. (1977) J. Gen. Physiol. 70, 567–590 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Murrell-Lagnado R. D., Aldrich R. W. (1993) J. Gen. Physiol. 102, 949–975 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Murrell-Lagnado R. D., Aldrich R. W. (1993) J. Gen. Physiol. 102, 977–1003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ogielska E. M., Zagotta W. N., Hoshi T., Heinemann S. H., Haab J., Aldrich R. W. (1995) Biophys. J. 69, 2449–2457 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ong B. H., Tomaselli G. F., Balser J. R. (2000) J. Gen. Physiol. 116, 653–662 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Pavlov E., Bladen C., Winkfein R., Diao C., Dhaliwal P., French R. J. (2005) Biophys. J. 89, 232–242 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Blunck R., Starace D. M., Correa A. M., Bezanilla F. (2004) Biophys. J. 86, 3966–3980 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Rey M. W., Ramaiya P., Nelson B. A., Brody-Karpin S. D., Zaretsky E. J., Tang M., Lopez de Leon A., Xiang H., Gusti V., Clausen I. G., Olsen P. B., Rasmussen M. D., Andersen J. T., Jørgensen P. L., Larsen T. S., Sorokin A., Bolotin A., Lapidus A., Galleron N., Ehrlich S. D., Berka R. M. (2004) Genome Biol. 5, R77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Van Trappen S., Mergaert J., Swings J. (2004) Int. J. Syst. Evol. Microbiol. 54, 1263–1269 [DOI] [PubMed] [Google Scholar]
- 29.Choudhary M., Zanhua X., Fu Y. X., Kaplan S. (2007) J. Bacteriol. 189, 1914–1921 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Ziemke F., Höfle M. G., Lalucat J., Rosselló-Mora R. (1998) Int. J. Syst. Bacteriol. 48, 179–186 [DOI] [PubMed] [Google Scholar]
- 31.Swingley W. D., Sadekar S., Mastrian S. D., Matthies H. J., Hao J., Ramos H., Acharya C. R., Conrad A. L., Taylor H. L., Dejesa L. C., Shah M. K., O'huallachain M. E., Lince M. T., Blankenship R. E., Beatty J. T., Touchman J. W. (2007) J. Bacteriol. 189, 683–690 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Strömpl C., Hold G. L., Lünsdorf H., Graham J., Gallacher S., Abraham W. R., Moore E. R., Timmis K. N. (2003) Int. J. Syst. Evol. Microbiol. 53, 1901–1906 [DOI] [PubMed] [Google Scholar]
- 33.Hümbelin M., Thomas A., Lin J., Li J., Jore J., Berry A. (2002) Gene 297, 129–139 [DOI] [PubMed] [Google Scholar]
- 34.Patton D. E., Isom L. L., Catterall W. A., Goldin A. L. (1994) J. Biol. Chem. 269, 17649–17655 [PubMed] [Google Scholar]
- 35.O'Neil K. T., DeGrado W. F. (1990) Science 250, 646–651 [DOI] [PubMed] [Google Scholar]
- 36.Lalik P. H., Krafte D. S., Volberg W. A., Ciccarelli R. B. (1993) Am. J. Physiol. 264, C803–C809 [DOI] [PubMed] [Google Scholar]
- 37.Swartz T. H., Ikewada S., Ishikawa O., Ito M., Krulwich T. A. (2005) Extremophiles 9, 345–354 [DOI] [PubMed] [Google Scholar]
- 38.Ito M., Hicks D. B., Henkin T. M., Guffanti A. A., Powers B. D., Zvi L., Uematsu K., Krulwich T. A. (2004) Mol. Microbiol. 53, 1035–1049 [DOI] [PubMed] [Google Scholar]
- 39.McEvoy M. M., Dahlquist F. W. (1997) Curr. Opin. Struct. Biol. 7, 793–797 [DOI] [PubMed] [Google Scholar]
- 40.Shimizu H., Iwamoto M., Konno T., Nihei A., Sasaki Y. C., Oiki S. (2008) Cell 132, 67–78 [DOI] [PubMed] [Google Scholar]
- 41.Blunck R., Cordero-Morales J. F., Cuello L. G., Perozo E., Bezanilla F. (2006) J. Gen. Physiol. 128, 569–581 [DOI] [PMC free article] [PubMed] [Google Scholar]